EQ-5D-5L health utility scores in Australian adults with inherited retinal diseases: A cross-sectional survey

被引:4
作者
Mcguinness, Myra B. [1 ,2 ,3 ,10 ]
Ayton, Lauren N. [1 ,2 ,4 ]
Schofield, Deborah [5 ]
Britten-Jones, Alexis Ceecee [1 ,4 ]
Chen, Fred K. [1 ,2 ,6 ,7 ]
Grigg, John R. [8 ,9 ]
Qi, Ziyi [3 ]
Kraindler, Joshua [5 ]
Shrestha, Rupendra [5 ]
Mack, Heather G. [1 ,2 ]
机构
[1] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia
[2] Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic, Australia
[5] Macquarie Univ, Macquarie Business Sch, GenIMPACT Ctr Econ Impacts Genom Med, Sydney, NSW, Australia
[6] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Incorporating Lions Eye Inst, Perth, WA, Australia
[7] Perth Childrens Hosp, Dept Ophthalmol, Nedlands, WA, Australia
[8] Univ Sydney, Save Sight Inst, Sydney, NSW, Australia
[9] Univ Sydney, Sydney Childrens Hosp Network, Save Sight Inst, Childrens Med Res Inst,Eye Genet Res Unit, Sydney, NSW, Australia
[10] Level 7,Peter Howson Wing,32 Gisborne St, East Melbourne, Vic 3002, Australia
关键词
health utility; inherited retinal disease; macular dystrophy; patient-reported outcome measures; patient-reported outcomes; retinitis pigmentosa; rod-cone dystrophy; vision-related quality of life; QUALITY-OF-LIFE; VORETIGENE NEPARVOVEC; CLINICAL-TRIALS; QUESTIONNAIRE; VISION; VALUES;
D O I
10.1111/aos.16634
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: Economic evaluations of interventions for ocular disease require utility scores that accurately represent quality of life in the target population. This study aimed to describe the distribution of EQ-5D-5L utility values among Australian adults with symptomatic inherited retinal diseases (IRDs) and to assess the relationship between these scores and vision-related quality of life.Methods: A survey was administered predominantly online in 2021. Participants completed the EQ-5D-5L general health utility instrument, the EQ vertical visual analogue scale (EQ-VAS) and the National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25). Self-reported IRD diagnoses were classified as being associated with central or widespread retinal involvement.Results: Responses from 647 participants aged 18-93 years were included, 50.1% were men and 77.6% had an IRD associated with widespread retinal involvement. The majority reported no problems with self-care and no pain/discomfort but did report anxiety/depression and problems with work, study, housework, or family/leisure activities. Most people with widespread involvement reported problems with mobility. Median EQ-5D-5L utility was 0.88 and 0.91 among people with widespread and central involvement, respectively (age and sex-adjusted p = 0.029); and median EQ-VAS was 75 and 80, respectively (adjusted p = 0.003). A moderate curvilinear correlation was observed between EQ-5D-5L and NEI-VFQ-25 composite score (Spearman's rho 0.69), but not all people with poor vision-related quality of life had low EQ-5D-5L utility values.Conclusions: EQ-5D-5L health utility values are correlated with vision-related quality of life among adults with IRDs. However, the EQ-5D-5L may not be sensitive to the full impact of vision impairment on quality of life.
引用
收藏
页码:e736 / e745
页数:10
相关论文
共 53 条
[1]   A comparison of methods for analyzing health-related quality-of-life measures [J].
Austin, PC .
VALUE IN HEALTH, 2002, 5 (04) :329-337
[2]   Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland [J].
Bhadhuri, Arjun ;
Droschel, Daniel ;
Guldimann, Mike ;
Jetschgo, Claudia ;
Banhazi, Judit ;
Schwenkglenks, Matthias ;
Sutherland, C. Simone .
BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
[3]   The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice [J].
Braithwaite, Tasanee ;
Calvert, Melanie ;
Gray, Alastair ;
Pesudovs, Konrad ;
Denniston, Alastair K. .
PATIENT-RELATED OUTCOME MEASURES, 2019, 10 :9-24
[4]   Victorian evolution of inherited retinal diseases natural history registry (VENTURE study): Rationale, methodology and initial participant characteristics [J].
Britten-Jones, Alexis Ceecee ;
O'Hare, Fleur ;
Edwards, Thomas L. ;
Ayton, Lauren N. .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 50 (07) :768-780
[5]   The safety and efficacy of gene therapy treatment for monogenic retinal and optic nerve diseases: A systematic review [J].
Britten-Jones, Alexis Ceecee ;
Jin, Rui ;
Gocuk, Sena A. ;
Cichello, Elise ;
O'Hare, Fleur ;
Hickey, Doron G. ;
Edwards, Thomas L. ;
Ayton, Lauren N. .
GENETICS IN MEDICINE, 2022, 24 (03) :521-534
[6]   Utility values associated with blindness in an adult population [J].
Brown, MM ;
Brown, GC ;
Sharma, S ;
Kistler, J ;
Brown, H .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (03) :327-331
[7]   Estimating quality-adjusted life years from patient-reported visual functioning [J].
Browne, C. ;
Brazier, J. ;
Carlton, J. ;
Alavi, Y. ;
Jofre-Bonet, M. .
EYE, 2012, 26 (10) :1295-1301
[8]   A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA [J].
Clemens, Susan ;
Begum, Nelufa ;
Harper, Catherine ;
Whitty, Jennifer A. ;
Scuffham, Paul A. .
QUALITY OF LIFE RESEARCH, 2014, 23 (08) :2375-2381
[9]   Psychosocial impacts of Mendelian eye conditions: A systematic literature review [J].
D'Amanda, Celeste S. ;
Nolen, Rosalie ;
Huryn, Laryssa A. ;
Turriff, Amy .
SURVEY OF OPHTHALMOLOGY, 2020, 65 (05) :562-580
[10]  
Daiger S.P., 2023, RETNET RETINAL INFOR